GeminIQ Website Logo

Viewing SYRA free

Subscribe for full history, 90+ metrics, screener, watchlist...

Syra Health Corp

SYRA

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
232222232330
Accounts Receivable Net Current
11111-1----1
Other Assets Current
000000000000
Assets Current
443334343451
Deferred Costs
-----------1
Property Plant And Equipment Net
000000000000
Operating Lease Right Of Use Asset
000000000000
Assets
443334443553
Liabilities And Stockhold…
Accounts Payable Current
----1000110-
Liabilities Current
Accrued Liabilities Current
000000000000
Deferred Revenue Current
1100010000-0
Operating Lease Liability Current
000000000000
Lines Of Credit Current
-----------0
Notes Payable Current
00000000000-
Liabilities Current
121111111112
Operating Lease Liability Noncurrent
------000---
Liabilities
121111111114
Stockholders Equity
Convertible Long Term Notes Payable
-----------1
Additional Paid In Capital
1212121212121212101093
Retained Earnings Accumulated Deficit
-9-9-10-10-9-9-9-8-8-7-5-4
Stockholders Equity
32222233234-1
Liabilities And Stockholders Equity
443334443553
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202610.00%8.00%34.00%---------
2025-11.46%4.17%4.17%20.00%12.00%1.33%2.99%29.85%19.40%127.62%357.14%423.81%
2024-7.95%-9.27%-20.66%-20.61%-69.24%-69.16%-25.31%-22.45%0.00%-46.29%-70.00%-75.71%
2023------6.72%-17.97%-11.72%-31.33%6.00%-0.67%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
3.13
2.48
4.06
3.05
3.25
2.88
5.46
4.63
3.14
4.04
5.25
0.52
Quick Ratio
3.13
2.48
4.06
3.05
3.25
2.88
5.46
4.63
3.14
4.04
5.25
0.52
Working Capital
2.55M
2.35M
2.06M
2.16M
2.38M
2.38M
2.74M
3.19M
1.93M
3.35M
3.87M
-1.14M
Leverage & Debt
Debt to Equity
0.45
0.67
0.32
0.48
0.44
0.52
0.28
0.33
0.55
0.32
0.23
-3.12
Interest Coverage TTM
6.88
-19.20
-68.15
-87.49
-98.59
-189.42
-241.34
-117.14
-93.05
-
-
-
Debt Ratio
0.31
0.40
0.24
0.32
0.30
0.34
0.22
0.25
0.35
0.24
0.18
1.47
Efficiency & Turnover
Asset Turnover TTM
2.22
1.99
2.24
1.95
2.40
1.95
1.86
2.82
2.85
-
-
-
Days Sales Outstanding TTM
53.16
41.51
40.39
45.09
40.12
-
31.13
-
-
-
-
-
Receivables Turnover TTM
6.87
8.79
9.04
8.10
9.10
-
11.72
-
-
-
-
-
Per Share Metrics
Diluted EPS TTM
0.01
-0.01
-0.08
-0.11
-0.12
-0.24
-0.50
-0.80
-0.87
-
-
-
Free Cash Flow Per Share TTM
-0.08
0.06
-0.04
-0.04
-0.06
-0.17
-0.39
-0.62
-0.77
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Margin Metrics
Gross Profit Margin TTM
39.35%
37.56%
34.43%
29.76%
29.08%
24.02%
20.71%
21.95%
22.32%
-
-
-
Operating Profit Margin TTM
0.92%
-3.14%
-12.51%
-16.94%
-18.19%
-34.55%
-47.17%
-58.61%
-61.94%
-
-
-
Net Profit Margin TTM
1.62%
-2.40%
-12.40%
-16.89%
-18.08%
-34.43%
-47.10%
-58.92%
-62.53%
-
-
-
Growth Metrics
Net Revenue Growth (1Y)
0.32%
-5.51%
-9.47%
-24.33%
-12.70%
-
-
-
-
-
-
-
Net Income Growth (1Y)
-108.97%
-93.42%
-76.16%
-78.31%
-74.76%
-
-
-
-
-
-
-
EPS Growth (1Y)
-108.13%
-93.62%
-84.81%
-86.80%
-86.04%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
64.29
-14.02
-1.14
-0.85
-0.89
-1.08
-0.83
-0.53
-1.57
-
-
-
P/B TTM
3.19
1.09
0.49
0.49
0.54
1.23
1.08
0.92
4.32
2.60
1.23
-10.64
P/S TTM
1.04
0.34
0.14
0.14
0.16
0.37
0.39
0.31
0.98
-
-
-
Market Cap
8.41M
2.57M
1.02M
1.07M
1.30M
3.01M
3.11M
3.08M
9.05M
8.96M
4.96M
13.08M
Enterprise Value
6.35M
-293.37K
-479.05K
-713.12K
-917.84K
597.09K
868.73K
623.02K
7.57M
5.82M
1.86M
14.82M
Calculated Values
Free Cash Flow TTM
-1.09M
755.97K
-447.75K
-531.51K
-700.50K
-1.98M
-2.94M
-4.49M
-5.09M
-
-
-
Net Debt
-2.05M
-2.86M
-1.50M
-1.79M
-2.22M
-2.42M
-2.24M
-2.46M
-1.48M
-3.14M
-3.10M
1.74M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-09-12Purchase
Owner: Prasad, Priya
Title: CFO and COO
Shares: 5,303
Price/Share: $0.38
Value: $2,015.14
Shares Owned: 10,295
Relationship: Director,Officer
Ownership: Indirect
2024-02-08Sale
Owner: Prasad, Priya
Title: CFO and COO
Shares: 500
Price/Share: $7.50
Value: $3,750.00
Shares Owned: 4,992
Relationship: Director,Officer
Ownership: Indirect
2023-12-14Purchase
Owner: Syed, Feroz
Title: -
Shares: 175
Price/Share: $1.42
Value: $248.50
Shares Owned: 1,825
Relationship: TenPercentOwner
Ownership: Direct
2023-12-07Purchase
Owner: Allam, Sandeep
Title: President and Chair
Shares: 206
Price/Share: $1.27
Value: $261.62
Shares Owned: 1,809
Relationship: Director,Officer
Ownership: Direct
2023-12-04Purchase
Owner: Vuppalanchi, Deepika
Title: CEO
Shares: 426
Price/Share: $1.17
Value: $498.42
Shares Owned: 426
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2025-06-30
1.45%
Inst. Shares: 172,533
Shares Outstanding: 11,939,169
2025-03-31
1.45%
Inst. Shares: 168,430
Shares Outstanding: 11,587,058
2024-12-31
6.92%
Inst. Shares: 522,658
Shares Outstanding: 7,551,576
2024-09-30
9.09%
Inst. Shares: 660,348
Shares Outstanding: 7,264,768
2024-06-30
1.05%
Inst. Shares: 69,230
Shares Outstanding: 6,602,421

Syra Health Corp (SYRA) — SEC Financial Statements & Analysis

Syra Health Corp (SYRA) is a services-employment agencies company, incorporated in DE. Syra Health Corp trades on OTC as: SYRA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Syra Health Corp reported a 0.32% year-over-year revenue growth, a Gross Profit Margin of 39.35% (TTM), a Debt-to-Equity ratio of 0.45x, a Price-to-Sales (P/S) ratio of 1.04x (TTM), a Price-to-Book (P/B) ratio of 3.19x (TTM), at a market cap of $8.41M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
0.32%
Gross Profit Margin TTM
39.35%
Debt To Equity
0.45x
P/S TTM
1.04x
P/B TTM
3.19x
Market Cap
$8.41M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Syra Health Corp in?

Syra Health Corp (SYRA) operates in the Services-Employment Agencies industry.

What is SYRA's market cap?

Syra Health Corp (SYRA) has a market capitalization of $8.41M as of 2026-06-30.

What is SYRA's P/E ratio?

Syra Health Corp (SYRA)'s trailing twelve month P/E ratio is 64.29x as of 2026-06-30.

What exchange does SYRA trade on?

Syra Health Corp (SYRA) trades on the OTC.

Where is Syra Health Corp incorporated?

Syra Health Corp is incorporated in DE.

Wall Street's data.
Main Street's price.